Manchester Explorer, L.P. - Oct 18, 2024 Form 4 Insider Report for SANUWAVE Health, Inc. (SNWV)

Signature
Manchester Explorer, L.P., By: /s/ James E. Besser, Managing Member of the General Partner
Stock symbol
SNWV
Transactions as of
Oct 18, 2024
Transactions value $
$0
Form type
4
Date filed
10/23/2024, 12:56 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNWV Common Stock Purchase Warrant Other -167K -100% 0 Oct 18, 2024 Common Stock, par value $0.001 167K $15.00 See footnote F1, F2, F3, F4
transaction SNWV Common Stock Purchase Warrant Other +150K 150K Oct 18, 2024 Common Stock, par value $0.001 150K $15.00 See footnote F1, F2, F3, F4
transaction SNWV Common Stock Purchase Warrant Other -167K -100% 0 Oct 18, 2024 Common Stock, par value $0.001 167K $25.13 See footnote F1, F2, F3, F4
transaction SNWV Common Stock Purchase Warrant Other +142K 142K Oct 18, 2024 Common Stock, par value $0.001 142K $25.13 See footnote F1, F2, F3, F4
transaction SNWV Common Stock Purchase Warrant Other -16.7K -100% 0 Oct 18, 2024 Common Stock, par value $0.001 16.7K $15.00 Direct F1, F2, F3, F5
transaction SNWV Common Stock Purchase Warrant Other +15K 15K Oct 18, 2024 Common Stock, par value $0.001 15K $15.00 Direct F1, F2, F3, F5
transaction SNWV Common Stock Purchase Warrant Other -16.7K -100% 0 Oct 18, 2024 Common Stock, par value $0.001 16.7K $25.13 Direct F1, F2, F3, F5
transaction SNWV Common Stock Purchase Warrant Other +14.2K 14.2K Oct 18, 2024 Common Stock, par value $0.001 14.2K $25.13 Direct F1, F2, F3, F5
transaction SNWV Common Stock Purchase Warrant Other -26.7K -100% 0 Oct 18, 2024 Common Stock, par value $0.001 26.7K $15.00 See footnote F1, F2, F6, F7
transaction SNWV Common Stock Purchase Warrant Other +24K 24K Oct 18, 2024 Common Stock, par value $0.001 24K $15.00 See footnote F1, F2, F6, F7
transaction SNWV Common Stock Purchase Warrant Other -26.7K -100% 0 Oct 18, 2024 Common Stock, par value $0.001 26.7K $25.13 See footnote F1, F2, F6, F7
transaction SNWV Common Stock Purchase Warrant Other +22.7K 22.7K Oct 18, 2024 Common Stock, par value $0.001 22.7K $25.13 See footnote F1, F2, F6, F7
transaction SNWV Common Stock Purchase Warrant Other -20K -100% 0 Oct 18, 2024 Common Stock, par value $0.001 20K $15.00 See footnote F1, F2, F4, F8
transaction SNWV Common Stock Purchase Warrant Other +18K 18K Oct 18, 2024 Common Stock, par value $0.001 18K $15.00 See footnote F1, F2, F4, F8
transaction SNWV Common Stock Purchase Warrant Other -20K -100% 0 Oct 18, 2024 Common Stock, par value $0.001 20K $25.13 See footnote F1, F2, F4, F8
transaction SNWV Common Stock Purchase Warrant Other +17K 17K Oct 18, 2024 Common Stock, par value $0.001 17K $25.13 See footnote F1, F2, F4, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 15, 2024, the Issuer filed a Certificate of Amendment to its Articles of Incorporation, as amended (the "Certificate of Amendment"), to implement a 1-for-375 reverse stock split (the "Reverse Stock Split") of Common Stock. As a result of the Reverse Stock Split, at 12:01 a.m. Mountain Time on October 18, 2024, every 375 shares of Common Stock then issued and outstanding automatically were combined into one share of Common Stock, with no change in par value per share. No fractional shares were outstanding following the Reverse Stock Split, and any fractional shares that would have resulted from the Reverse Stock Split will be settled in cash. The text of the Certificate of Amendment that effected the foregoing actions was included as Exhibit 3.1 of the 8-K and is incorporated herein by reference.
F2 Pursuant to a letter agreement entered into by certain of the Reporting Persons and the Issuer, and with the consent of the Board of Directors of the Issuer, the Reporting Persons agreed to exchange the reported warrants for warrants with different terms.
F3 The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant included as Exhibit 4.2 of the Issuer's 8-K filed on August 8, 2022 ("Exhibit 4.2"). The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2.
F4 The reported securities and warrants are owned directly by Manchester Explorer, L.P. ("Explorer") and may be deemed to be indirectly beneficially owned by (i) Manchester Management Company, LLC ("Manchester Management"), the general partner of Explorer, (ii) Manchester Management PR, LLC ("Manchester PR"), the investment adviser to Manchester Management, (iii) James E. Besser, the managing member of Manchester Management and Manchester PR, and (iv) Morgan Frank, who serves as a portfolio manager and as a consultant for Explorer. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F5 The reported securities and warrants are directly owned by Morgan C. Frank in his personal capacity.
F6 The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrant does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.4 of the Issuer's S-1/A filed on December 22, 2022, which is incorporated by reference.
F7 The reported securities and warrants are owned directly by JEB Partners, L.P. ("JEB Partners") and may be deemed to be indirectly beneficially owned by (i) Manchester Management, the general partner of JEB Partners, (ii) Manchester PR, the investment adviser to Manchester Management, and (iii) James E. Besser, the managing member of Manchester Management and Manchester PR. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F8 The warrants may be exercised into shares by the Reporting Persons pursuant to a formula contained in the Common Stock Purchase Warrant. The exercise of the reported warrants is subject to the limitations and conditions on exercise set forth in the Common Stock Purchase Warrant. The foregoing description of the warrants does not purport to be complete and is subject to and qualified in its entirety by reference to Exhibit 4.2, which is incorporated by reference.

Remarks:

This is the first part of a Form 4 filing for the Reporting Persons. There are two parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.